• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱胺对转谷氨酰胺酶2的抑制机制。

Mechanism for the inhibition of transglutaminase 2 by cystamine.

作者信息

Jeitner Thomas M, Delikatny E James, Ahlqvist Jenny, Capper Hugh, Cooper Arthur J L

机构信息

Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

出版信息

Biochem Pharmacol. 2005 Mar 15;69(6):961-70. doi: 10.1016/j.bcp.2004.12.011.

DOI:10.1016/j.bcp.2004.12.011
PMID:15748707
Abstract

Cystamine is neuroprotective in a number of models of neurodegeneration. The therapeutic benefit of cystamine has been attributed, in part, to its inhibition of transglutaminase activity. Cystamine [beta-mercaptoethanolamine (MEA) disulfide] is reduced within cells to MEA which is largely responsible for the in vivo effects of its disulfide precursor. In the current study, the amine group of MEA was shown to act as a transglutaminase (TG) substrate resulting in the formation of N(beta)-(gamma-l-glutamyl)-MEA bonds. The formation of such bonds would compete with the generation of other TG-catalyzed reactions that may contribute to neurodegeneration such as polyamination, protein cross-linking, deamination and the covalent attachment of ceramide to proteins. The demonstration that cystamine-derived MEA can form N(beta)-(gamma-l-glutamyl)-MEA bonds offers a unique tool for identifying the TG substrates that occur in diseased brains in vivo. Structure-function studies also indicated that the mercapto group of MEA significantly influences the substrate behavior of this compound. These structure-function studies also identified the following hierarchy of physico-chemical characteristics: hydrophobicity > S as the group VIII atom > distance separating the N and group VIII atom, as the major determinants contributing to the substrate behavior for low-molecular weight amine substrates of TG 2.

摘要

胱胺在多种神经退行性疾病模型中具有神经保护作用。胱胺的治疗益处部分归因于其对转谷氨酰胺酶活性的抑制。胱胺(β-巯基乙醇胺(MEA)二硫化物)在细胞内被还原为MEA,MEA在很大程度上决定了其二硫化物前体的体内效应。在本研究中,MEA的胺基被证明可作为转谷氨酰胺酶(TG)的底物,导致形成N(β)-(γ-L-谷氨酰基)-MEA键。这种键的形成将与其他可能导致神经退行性变的TG催化反应竞争,如多胺化、蛋白质交联、脱氨以及神经酰胺与蛋白质的共价连接。胱胺衍生的MEA能够形成N(β)-(γ-L-谷氨酰基)-MEA键这一发现,为识别体内患病大脑中存在的TG底物提供了一个独特的工具。结构-功能研究还表明,MEA的巯基对该化合物的底物行为有显著影响。这些结构-功能研究还确定了以下物理化学特性的层级关系:疏水性>作为第VIII族原子的S>N与第VIII族原子之间的距离,这是决定TG 2低分子量胺底物底物行为的主要因素。

相似文献

1
Mechanism for the inhibition of transglutaminase 2 by cystamine.胱胺对转谷氨酰胺酶2的抑制机制。
Biochem Pharmacol. 2005 Mar 15;69(6):961-70. doi: 10.1016/j.bcp.2004.12.011.
2
Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.组织转谷氨酰胺酶II(tTG)与血管内皮生长因子受体2(VEGFR-2)之间的复合物形成:调节内皮细胞对VEGF反应的潜在机制。
Exp Cell Res. 2006 Oct 1;312(16):2973-82. doi: 10.1016/j.yexcr.2006.05.019. Epub 2006 Jun 7.
3
A sensitive fluorometric assay for tissue transglutaminase.一种用于组织转谷氨酰胺酶的灵敏荧光测定法。
Anal Biochem. 2001 May 15;292(2):198-206. doi: 10.1006/abio.2001.5040.
4
Effect of cystamine on blood pressure and vascular characteristics in spontaneously hypertensive rats.胱胺对自发性高血压大鼠血压及血管特性的影响。
J Vasc Res. 2011;48(6):476-84. doi: 10.1159/000327773. Epub 2011 Jul 20.
5
Chronic cystamine treatment inhibits small artery remodelling in rats.长期胱胺治疗可抑制大鼠小动脉重塑。
J Vasc Res. 2007;44(6):471-82. doi: 10.1159/000106465. Epub 2007 Jul 26.
6
Cystamine and cysteamine as inhibitors of transglutaminase activity .半胱胺和胱胺作为转谷氨酰胺酶活性的抑制剂。
Biosci Rep. 2018 Sep 5;38(5). doi: 10.1042/BSR20180691. Print 2018 Oct 31.
7
Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.组织转谷氨酰胺酶的可逆性竞争性肉桂酰三唑抑制剂
Chem Biol Drug Des. 2008 Sep;72(3):189-96. doi: 10.1111/j.1747-0285.2008.00696.x. Epub 2008 Aug 19.
8
Cystamine prevents ischemia-reperfusion injury by inhibiting polyamination of RhoA.半胱胺通过抑制RhoA的多胺化来预防缺血再灌注损伤。
Biochem Biophys Res Commun. 2008 Jan 18;365(3):509-14. doi: 10.1016/j.bbrc.2007.11.007. Epub 2007 Nov 20.
9
Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells.胱胺抑制谷氨酸暴露的星形胶质细胞中的转谷氨酰胺酶和半胱天冬酶-3切割。
J Neurosci Res. 2003 Oct 1;74(1):52-9. doi: 10.1002/jnr.10702.
10
Potential of transglutaminase 2 as a therapeutic target.转谷氨酰胺酶 2 作为治疗靶点的潜力。
Expert Opin Ther Targets. 2010 Sep;14(9):989-1003. doi: 10.1517/14728222.2010.510134.

引用本文的文献

1
Cystamine reduces vascular stiffness in Western diet-fed female mice.半胱胺可降低西方饮食喂养雌性小鼠的血管僵硬度。
Am J Physiol Heart Circ Physiol. 2022 Feb 1;322(2):H167-H180. doi: 10.1152/ajpheart.00431.2021. Epub 2021 Dec 10.
2
Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis.转谷氨酰胺酶 2 作为脓毒症炎症的标志物和治疗靶点。
Int J Mol Sci. 2021 Feb 14;22(4):1897. doi: 10.3390/ijms22041897.
3
Regulation of coenzyme A levels by degradation: the 'Ins and Outs'.辅酶 A 水平的降解调控:“内与外”。
Prog Lipid Res. 2020 Apr;78:101028. doi: 10.1016/j.plipres.2020.101028. Epub 2020 Mar 29.
4
Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.人组织转谷氨酰胺酶 2 结构:寻找干扰交联介导活性的线索。
Int J Mol Sci. 2020 Mar 23;21(6):2225. doi: 10.3390/ijms21062225.
5
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against .抑制转谷氨酰胺酶 2 作为一种针对 的潜在的宿主靶向治疗。
Front Immunol. 2020 Jan 24;10:3042. doi: 10.3389/fimmu.2019.03042. eCollection 2019.
6
Cystamine and cysteamine as inhibitors of transglutaminase activity .半胱胺和胱胺作为转谷氨酰胺酶活性的抑制剂。
Biosci Rep. 2018 Sep 5;38(5). doi: 10.1042/BSR20180691. Print 2018 Oct 31.
7
ECM Cross-Linking Regulates Invadopodia Dynamics.ECM 交联调节侵袭伪足动力学。
Biophys J. 2018 Mar 27;114(6):1455-1466. doi: 10.1016/j.bpj.2018.01.027.
8
Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism.半胱胺和双硫仑通过氧化机制抑制人转谷氨酰胺酶2 。
Biochemistry. 2018 Jun 19;57(24):3359-3363. doi: 10.1021/acs.biochem.8b00204. Epub 2018 Mar 28.
9
A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury.一项药物遗传学发现:半胱胺可预防氟哌啶醇诱导的毒性及缺血性脑损伤。
Genetics. 2016 May;203(1):599-609. doi: 10.1534/genetics.115.184648. Epub 2016 Mar 18.
10
Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries.转谷氨酰胺酶2和电压门控钾通道在胱胺对大鼠肠系膜小动脉血管舒张作用中的参与情况。
Br J Pharmacol. 2016 Mar;173(5):839-55. doi: 10.1111/bph.13393. Epub 2016 Jan 27.